Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 15/20 | 0.53 |
| ▸ | USP2 | O75604 | 10/20 | 0.53 |
| ▸ | SLCO1B3 | Q9NPD5 | 3/20 | 0.47 |
| ▸ | SLCO1B1 | Q9Y6L6 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29574101 | 0.84 | CYP3A4 (0.75) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL18969706 | 0.84 | CYP3A4 (0.75) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL29385694 | 0.84 | CYP3A4 (0.75) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL22040140 | 0.82 | CYP3A4 (0.56) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL10050918 | 0.77 | CYP3A4 (0.70) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL18324173 | 0.72 | CYP3A4 (0.63) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| Nomilin SCHEMBL691775 | 0.72 | CYP3A4 (0.80) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| Nomilin SCHEMBL29387920 | 0.72 | CYP3A4 (0.80) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL22899842 | 0.71 | CYP3A4 (0.69) | CYP3A4USP2SLCO1B3SLCO1B1MAPT | |
| SCHEMBL22039169 | 0.71 | CYP3A4 (0.61) | CYP3A4USP2SLCO1B3SLCO1B1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11253567-B2 | Citrus seed extract-containing composition, food, drug, and method for producing citrus seed extract-containing composition | KIKKOMAN CORPORATION (JP) | 2022-02-22 | — | — | US | disclosed |
| US-20200164018-A1 | CITRUS SEED EXTRACT-CONTAINING COMPOSITION, FOOD, DRUG, AND METHOD FOR PRODUCING CITRUS SEED EXTRACT-CONTAINING COMPOSITION | KIKKOMAN CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11253567-B2 | Citrus seed extract-containing composition, food, drug, and method for producing citrus seed extract-containing composition | OCIAD1, MLN, OCIAD2 | CYP3A4 330/4885USP2 3643/4885SLCO1B3 1798/4885 |
| US-20200164018-A1 | CITRUS SEED EXTRACT-CONTAINING COMPOSITION, FOOD, DRUG, AND METHOD FOR PRODUCING CITRUS SEED EXTRACT-CONTAINING COMPOSITION | OCIAD1, MLN, OCIAD2 | CYP3A4 330/4885USP2 3643/4885SLCO1B3 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.